Skip to Main Content
Contribute Try STAT+ Today

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and refreshing, because that oh-so familiar routine of Zoom meetings, Skype calls, and deadlines has predictably returned. To cope, we are pursuing the usual ritual of firing up the coffee kettle and brewing cups of stimulation. Our choice today is cinnamon mocha. Yum. Meanwhile, here is the latest menu of tidbits to help you along on your journey. We hope today is productive and meaningful. Stay in touch and stay safe — wear a mask. …

The Moderna (MRNA) Covid-19 vaccine is strongly effective, a development that is building excitement about the potential of controlling the global pandemic, STAT explains. The vaccine reduced the risk of infection by 94.5%. There were 95 cases of infection among patients who received placebo in a 30,000-patient study and only five infections in patients who developed Covid-19 after receiving the vaccine, mRNA-1273. The news comes one week after similar results from Pfizer (PFE) and BioNTech (BNTX), which announced broadly similar results.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.